Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Sánchez Azofra (Madrid, Spain), C. Cisneros Serrano (Madrid, Spain), B. Aldave Orzaiz (Madrid, Spain), E. Ávalos Pérez-Urria (Madrid, Spain), A. Martínez Meca (Madrid, Spain), C. Acosta Gutierrez (Madrid, Spain), A. Martinez Vergara (Madrid, Spain), M. Erro Iribarren (Madrid, Spain), A. Roca Noval (Madrid, Spain), M. Sanz Pastor (Madrid, Spain), J. Soriano (Madrid, Spain), J. Ancochea Bermúdez (Madrid, Spain). Can high doses of inhaled corticosteroids increase the level of total serum cholesterol?: a retrospective cohort study.. 2555

Member's Comments

No comment yet.

Related content which might interest you: Inhaled steroids doses to obtain asthma control in children: a randomised concurrent cohort study Source: Annual Congress 2009 - Clinical advances in childhood asthma Year: 2009 Prospective follow-up of novel bone turnover markers in asthmatics exposed to low or high doses of inhaled ciclesonide over 1 year Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 For how much time and with which dose of inhaled steroids it is possible to maintain asthma control? A randomized prospective study Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Treatment of patients with uncontrolled asthma using high dose inhaled corticosteroids administered by controlled inhalation – a retrospective analysis Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 Three-year prospective cohort study of growth in asthmatic children prescribed appropriate inhaled corticosteroid (ICS) doses Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004 Short term reductions in inhaled glucocorticoid doses in children with asthma may be associated with increased levels of serum eosinophil protein X Source: Eur Respir J 2001; 18: Suppl. 33, 451s Year: 2001 A preliminary study to identify correlations between blood glucose levels and cardiorespiratory observations in acute asthma patients receiving nebulised salbutamol. Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Real-world effectiveness of omalizumab in allergic asthma patients with low or high blood eosinophils: A retrospective claims analysis study Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 A preliminary study to determine the effects of nebulised salbutamol on blood glucose levels during an acute asthma exacerbation. Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 The effect of methylxanthine, corticosteroid, and N -acetylcystein on plasma oxidant/antioxidant levels in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 215s Year: 2001 Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020 Year: 2021 Retrospective review of studies shows that patients receiving salmeterol plus ICS have fewer serious asthma exacerbations vs patients on ICS alone, regardless of ethnic origin Source: Eur Respir J 2005; 26: Suppl. 49, 429s Year: 2005 The patterns of inadequate drug administration in children with asthma: a multi-center retrospective study Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002 Use of Inhaled corticosteroid (ICS)-containing regimen for COPD patients with high or low blood eosinophilia: A meta-analysis Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Close correlation between cumulative corticosteroid dose and weight gain in a German cohort of sarcoid patients. Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Adding montelukast versus doubling the budesonide dose in persistent asthma: a subgroup analysis of the COMPACT study Source: Eur Respir J 2002; 20: Suppl. 38, 388s Year: 2002 Effect of high or low-medium accumulated dose regimes of systemic corticosteroids for hospitalised patients with exacerbated chronic obstructive pulmonary disease: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021 “Stepping down” in mild-to-moderate asthmatic children being well controlled while receiving low doses of inhaled corticosteroids (ICS): Daily vs. cyclical ICS administration (prospective, randomized, multicentre, open-label trial) Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013 Low agreement between current and long-term asthma control in children: The PACMAN cohort study Source: Annual Congress 2011 - Treating childhood asthma Year: 2011 An investigator driven, single-centre randomised, double blind comparative study of standard vs high dose intravenous meropenem, in adult cystic fibrosis patients Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010